Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07754474
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or ObesityBoehringer IngelheimNot Yet RecruitingPhase 1
NCT07754474Not Yet Recruiting
Phase 1
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerate...Boehringer Ingelheim
NCT07754019
Serum and Urinary sCD163 in IgA NephropathyBezmialem Vakif UniversityActive Not Recruiting
NCT07754019Active Not Recruiting
—
Serum and Urinary sCD163 in IgA NephropathyBezmialem Vakif Universit...
NCT07756645
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult ParticipantsAbbVieNot Yet RecruitingPhase 3
NCT07756645Not Yet Recruiting
Phase 3
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembro...AbbVie
NCT07754318
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic CardiovascularNot Yet RecruitingNot Applicable
NCT07754318Not Yet Recruiting
Not Applicable
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic Cardiovascular
NCT07755059
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated CirrhosisMassachusetts General HospitalNot Yet RecruitingNot Applicable
NCT07755059Not Yet Recruiting
Not Applicable
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Asci...Massachusetts General Hos...
NCT07755319
Safety and Feasibility of FMT for Immune Recovery After HSCTThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 1
NCT07755319Not Yet Recruiting
Phase 1
Safety and Feasibility of FMT for Immune Recovery After HSCTThe First Affiliated Hosp...
NCT07754812
Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLCShanghai Pulmonary Hospital, Shanghai, ChinaRecruitingPhase 4
NCT07754812Recruiting
Phase 4
Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant T...Shanghai Pulmonary Hospit...
NCT07755826
Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive Tumors in JapanBristol-Myers SquibbRecruiting
NCT07755826Recruiting
—
Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion...Bristol-Myers Squibb
NCT07756580
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar LinesAbbVieNot Yet RecruitingPhase 1
NCT07756580Not Yet Recruiting
Phase 1
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Follow...AbbVie
NCT07756008
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07756008Not Yet Recruiting
Phase 2
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without...Sun Yat-Sen Memorial Hosp...
NCT07754773
Motus Nova Foot Device for Patients With HemiplegiaMultiCare Health System Research InstituteNot Yet RecruitingNot Applicable
NCT07754773Not Yet Recruiting
Not Applicable
Motus Nova Foot Device for Patients With HemiplegiaMultiCare Health System R...
NCT07755488
Change in Shoe Size and Forefoot Morphological Parameters After Scarf + P1 Osteotomy for Hallux Valgus: a Prospective Study Using Surface 3D ScanningGroupe Hospitalier Diaconesses Croix Saint-SimonNot Yet RecruitingNot Applicable
NCT07755488Not Yet Recruiting
Not Applicable
Change in Shoe Size and Forefoot Morphological Parameters After Scarf + P1 Osteo...Groupe Hospitalier Diacon...
NCT07755046
Repetitive Transcranial Magnetic Stimulation for Alcohol Use DisorderTing-Gang ChangCompletedNot Applicable
NCT07755046Completed
Not Applicable
Repetitive Transcranial Magnetic Stimulation for Alcohol Use DisorderTing-Gang Chang
NCT07755358
Effects of an Eight-Week Small-Sided Games Training Program on Aerobic Endurance and Passing Performance in Adolescent Soccer PlayersIstanbul Gelisim UniversityCompletedNot Applicable
NCT07755358Completed
Not Applicable
Effects of an Eight-Week Small-Sided Games Training Program on Aerobic Endurance...Istanbul Gelisim Universi...
NCT07754578
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use PharmacotherapyMedical University of South CarolinaNot Yet RecruitingPhase 2
NCT07754578Not Yet Recruiting
Phase 2
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use PharmacotherapyMedical University of Sou...
NCT07755787
Ultrasound Assessment of Pediatric Fracture Healing With the PLUS ScoreMasaryk UniversityNot Yet Recruiting
NCT07755787Not Yet Recruiting
—
Ultrasound Assessment of Pediatric Fracture Healing With the PLUS ScoreMasaryk University
NCT07755345
Weighted vs Unweighted Plyometric Conditioning on Vertical Jump Performance in Young Male Soccer PlayersIstanbul Gelisim UniversityCompletedNot Applicable
NCT07755345Completed
Not Applicable
Weighted vs Unweighted Plyometric Conditioning on Vertical Jump Performance in Y...Istanbul Gelisim Universi...
NCT07755605
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder: A Randomized Controlled TrialSamsung Medical CenterRecruitingNot Applicable
NCT07755605Recruiting
Not Applicable
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Dis...Samsung Medical Center
NCT07754409
Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Advanced Lung Cancer Which Include Immune Checkpoint Inhibitor.Göteborg UniversityNot Yet Recruiting
NCT07754409Not Yet Recruiting
—
Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Adv...Göteborg University
Result Breakdown
Not yet recruiting13 (65%)
Recruiting3 (15%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 13 (15%)
Phase 22 (10%)
Phase 31 (5%)
Phase 41 (5%)